TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapyChristopher B. Rodell, Ralph Weissleder, Sean P. Arlauckas et al.|Nature Biomedical Engineering|2018Cited by 1.1k
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher Garris, Mikaël J. Pittet, Marcel P. Trefny et al.|Immunity|2018Cited by 937
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapySean P. Arlauckas, Mikaël J. Pittet, Christopher Garris et al.|Science Translational Medicine|2017Cited by 654
IRF3 and type I interferons fuel a fatal response to myocardial infarctionKevin R. King, Ralph Weissleder, Aaron D. Aguirre et al.|Nature Medicine|2017Cited by 571
Arg1 expression defines immunosuppressive subsets of tumor-associated macrophagesSean P. Arlauckas, Ralph Weissleder, Seth B. Garren et al.|Theranostics|2018Cited by 339